Clinical Trials Directory

Trials / Completed

CompletedNCT06125626

Prevention of Traveler's Diarrhea

Prevention of Traveler's Diarrhea While Crossing the Amazon Forest by Bike With a Supplement Based on Lacticaseibacillus Rhamnosus LR04 + Streptococcus Thermophilus FP4 + Bifidobacterium Brevis BR03: a Phase Two, Randomized, Placebo-controlled, Double-blind, Cross-over Pilot Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
3 (actual)
Sponsor
University of Palermo · Academic / Other
Sex
Male
Age
Healthy volunteers
Accepted

Summary

The prevention of traveller's diarrhea makes use of the selection of foods and drinks, the purification of water, the use of pharmacological substances such as bismuth salicylate and rifaximin (which can only be taken for short periods). The very attractive prospect of preventing travellers' diarrhea without systemic antibiotics has fueled interest in probiotics for this purpose. However, not all probiotics are identical, and the results of studies conducted with a particular agent cannot be generalized to indicate that any probiotic agent would be successful in the same clinical situation. Probiotics such as Lactobacillus GG have been shown to reduce the incidence of diarrhea in travelers in randomized controlled trials. In contrast, another Lactobacillus preparation, non-viable Lactobacillus acidophilus, showed no benefit over placebo in a randomized, double-blind, controlled trial of 174 travelers. The reasons for this are unclear, but could be related to the fact that the bacteria were not viable or a peculiarity of the strain selected for testing.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticalA daily sachet of Lacticaseibacillus rhamnosus LR04 + Streptococcus thermophilus FP4 + Bifidobacterium breve BR03 will be given to this group
OTHERPlaceboA daily sachet of placebo will be given to this groups

Timeline

Start date
2023-07-10
Primary completion
2023-10-07
Completion
2023-10-10
First posted
2023-11-09
Last updated
2023-11-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06125626. Inclusion in this directory is not an endorsement.